These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 1927484)

  • 1. Intratympanic gentamicin therapy for Menière's disease placed by a tubal catheter with systematic isosorbide.
    Yamazaki T; Hayashi M; Komatsuzaki A
    Acta Otolaryngol Suppl; 1991; 481():613-6. PubMed ID: 1927484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intratympanic gentamycin therapy for Menière's disease placed by tubal catheter with systemic isosorbide.
    Yamazaki T; Hayashi M; Hayashi N; Kozaki H
    Arch Otorhinolaryngol; 1988; 245(3):170-4. PubMed ID: 3178565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term hearing outcome in patients receiving intratympanic gentamicin for Ménière's disease.
    Wu IC; Minor LB
    Laryngoscope; 2003 May; 113(5):815-20. PubMed ID: 12792316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intratympanic gentamicin for control of vertigo in Meniere's disease: vestibular signs that specify completion of therapy.
    Minor LB
    Am J Otol; 1999 Mar; 20(2):209-19. PubMed ID: 10100525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratympanic gentamicin for intractable Meniere's disease.
    Perez N; Martín E; García-Tapia R
    Laryngoscope; 2003 Mar; 113(3):456-64. PubMed ID: 12616197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hearing loss after intratympanic gentamicin therapy for unilateral Ménière's Disease.
    Martin E; Perez N
    Otol Neurotol; 2003 Sep; 24(5):800-6. PubMed ID: 14501459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of endolymphatic shunt surgery for Ménière's disease: comparison with intratympanic gentamicin on vertigo control and hearing loss.
    Derebery MJ; Fisher LM; Berliner K; Chung J; Green K
    Otol Neurotol; 2010 Jun; 31(4):649-55. PubMed ID: 20431498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intratympanic mixture gentamicin and dexamethasone versus dexamethasone for unilateral Meniere's disease.
    Öztürk K; Ata N
    Am J Otolaryngol; 2019; 40(5):711-714. PubMed ID: 31262549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratympanic therapy for Ménière's disease. High-concentration gentamicin with round-window protection.
    Quaranta A; Aloisi A; De Benedittis G; Scaringi A
    Ann N Y Acad Sci; 1999 Nov; 884():410-24. PubMed ID: 10842610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intratympanic methylprednisolone versus gentamicin in patients with unilateral Ménière's disease: a randomised, double-blind, comparative effectiveness trial.
    Patel M; Agarwal K; Arshad Q; Hariri M; Rea P; Seemungal BM; Golding JF; Harcourt JP; Bronstein AM
    Lancet; 2016 Dec; 388(10061):2753-2762. PubMed ID: 27865535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intratympanic gentamicin in Menière's disease].
    Huang W; Xu H; Gao B
    Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2004 Jan; 18(1):14-6. PubMed ID: 15088342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intratympanic therapy for Ménière's disease: effect of administration of low concentration of gentamicin.
    Quaranta A; Scaringi A; Aloidi A; Quaranta N; Salonna I
    Acta Otolaryngol; 2001 Apr; 121(3):387-92. PubMed ID: 11425206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratympanic gentamicin treatment after endolymphatic sac surgery.
    Gouveris H; Lange G; Mann WJ
    Acta Otolaryngol; 2005 Nov; 125(11):1180-3. PubMed ID: 16353396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intratympanic gentamicin for Ménière's disease or syndrome.
    Pullens B; van Benthem PP
    Cochrane Database Syst Rev; 2011 Mar; (3):CD008234. PubMed ID: 21412917
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of intractable Menière's disease with intratympanic gentamicin: review of the University of Ottawa experience.
    Corsten M; Marsan J; Schramm D; Robichaud J
    J Otolaryngol; 1997 Dec; 26(6):361-4. PubMed ID: 9438932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intratympanic gentamicin in patients with Ménière's disease: analysis of our protocol].
    Martín Sanz E; Pérez Fernández N
    Acta Otorrinolaringol Esp; 2004; 55(6):270-6. PubMed ID: 15491114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The long-term results of treatment of Ménière's disease with intratympanic injections of gentamicin].
    Gawęcki W; Szyfter W; Lączkowska-Przybylska J; Szyfter-Harris J
    Otolaryngol Pol; 2012; 66(1):20-6. PubMed ID: 22381010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intratympanic gentamicin therapy for Ménière's disease.
    Hirsch BE; Kamerer DB
    Am J Otol; 1997 Jan; 18(1):44-51. PubMed ID: 8989951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratympanic steroid versus gentamicin for treatment of refractory Meniere's disease: A meta-analysis.
    Lee SY; Kim YS; Jeong B; Carandang M; Koo JW; Oh SH; Lee JH
    Am J Otolaryngol; 2021; 42(6):103086. PubMed ID: 34098455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distortion product otoacoustic emissions after intratympanic gentamicin therapy for unilateral Ménière's disease.
    Perez N; Boleas MS; Martin E
    Audiol Neurootol; 2005; 10(2):69-78. PubMed ID: 15650298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.